At the recent CIR virtual conference, Dr Ilse Tonk presented an industry case study on Endocrine Disruptors (ED). Discussing the assessment of ED properties for active substances and products, the difficulties in satisfying testing requirements, the market impacts of ED classification and effective substitution and phase out.